Science Explorer Back to mapMap
Discussion
Company · Lausanne · Switzerland

Galderma (Switzerland)

galderma.comROR OpenAlex
Research works
53
▲ 46% vs 2018-21
Citations
536
10.0 per fractional work
Top-10% rate
11.1%
all institutions 10.0%
Open access
61%
world 40%
International
82%
world 18%
Galderma (Switzerland)

Not ranked overall: Galderma (Switzerland) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Which fields of science does Galderma (Switzerland) work in?

In 2022-now, 76% of research at Galderma (Switzerland) is in Health Sciences, 19% in Life Sciences. Its largest fields are Medicine (72%), Immunology and Microbiology (10%), Biochemistry, Genetics and Molecular Biology (6%). It does 2.6× the world's share of Health Sciences.

Health Sciences: 23 fractional works · 76.1% of its workMedicine: 21 fractional works · 72.1% of its workDermatology: 12 fractional works · 41.8% of its workRheumatology: 2 fractional works · 6.2% of its workImmunology and Allergy: 2 fractional works · 5.3% of its workEpidemiology: 2 fractional works · 5.2% of its workSurgery: 1 fractional works · 2.3% of its workPhysiology: 1 fractional works · 2.0% of its workInfectious Diseases: 0 fractional works · 1.5% of its workPathology and Forensic Medicine: 0 fractional works · 1.4% of its workRehabilitation: 0 fractional works · 1.4% of its workOncology: 0 fractional works · 0.7% of its workUrology: 0 fractional works · 0.7% of its workPediatrics, Perinatology and Child Health: 0 fractional works · 0.6% of its workRadiology, Nuclear Medicine and Imaging: 0 fractional works · 0.6% of its workNeurology: 0 fractional works · 0.5% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workCardiology and Cardiovascular Medicine: 0 fractional works · 0.4% of its workNephrology: 0 fractional works · 0.4% of its workComplementary and alternative medicine: 0 fractional works · 0.3% of its workPulmonary and Respiratory Medicine: 0 fractional works · 0.3% of its workHealth Professions: 1 fractional works · 2.2% of its workSpeech and Hearing: 0 fractional works · 1.7% of its workGeneral Health Professions: 0 fractional works · 0.5% of its workNursing: 0 fractional works · 0.9% of its workNutrition and Dietetics: 0 fractional works · 0.9% of its workDentistry: 0 fractional works · 0.7% of its workOral Surgery: 0 fractional works · 0.4% of its workOrthodontics: 0 fractional works · 0.4% of its workVeterinary: 0 fractional works · 0.1% of its workLife Sciences: 6 fractional works · 19.1% of its workImmunology and Microbiology: 3 fractional works · 9.8% of its workImmunology: 3 fractional works · 9.8% of its workBiochemistry, Genetics and Molecular Biology: 2 fractional works · 5.5% of its workMolecular Biology: 1 fractional works · 3.0% of its workCell Biology: 1 fractional works · 2.1% of its workGenetics: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workPharmacology, Toxicology and Pharmaceutics: 0 fractional works · 1.5% of its workPharmaceutical Science: 0 fractional works · 0.8% of its workPharmacology: 0 fractional works · 0.7% of its workNeuroscience: 0 fractional works · 1.4% of its workCognitive Neuroscience: 0 fractional works · 0.5% of its workNeurology: 0 fractional works · 0.4% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 1.0% of its workAquatic Science: 0 fractional works · 0.4% of its workInsect Science: 0 fractional works · 0.4% of its workEcology, Evolution, Behavior and Systematics: 0 fractional works · 0.2% of its workSocial Sciences: 1 fractional works · 3.4% of its workPsychology: 1 fractional works · 3.4% of its workClinical Psychology: 1 fractional works · 2.0% of its workExperimental and Cognitive Psychology: 0 fractional works · 1.4% of its workPhysical Sciences: 0 fractional works · 1.5% of its workChemistry: 0 fractional works · 0.7% of its workSpectroscopy: 0 fractional works · 0.5% of its workAnalytical Chemistry: 0 fractional works · 0.3% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.3% of its workMaterials Science: 0 fractional works · 0.1% of its workALL ITS WORKGalderma(Switzerland)30fractional works, 2022-now
Life Sciences19%Physical Sciences1%Health Sciences76%Social Sciences3%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 14 fields, with their numbers
    1. Medicine2172.1%
    2. Health Professions12.2%
    3. Nursing00.9%
    4. Dentistry00.7%
    5. Veterinary00.1%
    1. Immunology and Microbiology39.8%
    2. Biochemistry, Genetics and Molecular Biology25.5%
    3. Pharmacology, Toxicology and Pharmaceutics01.5%
    4. Neuroscience01.4%
    5. Agricultural and Biological Sciences01.0%
    1. Psychology13.4%
    1. Chemistry00.7%
    2. Engineering00.6%
    3. Materials Science00.1%
All of science, and how each field's share has moved since 1950: the Science domain explorer

What does Galderma (Switzerland) specialise in?

Where its research is concentrated relative to its size: Medicine takes 3.8× the share of its output that it takes of world research.

  1. MedicineField · 21.3 works3.8×
  2. Health SciencesDomain · 22.5 works3.3×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.20× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 1.03× its world share, 2 worksBiochemistry, Geneti…Immunology and Microbiology: 9.70× its world share, 3 worksImmunology and Micro…Neuroscience: 0.83× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.16× its world share, 0 worksPharmacology, Toxico…Chemistry: 0.48× its world share, 0 worksChemistryEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 0.03× its world share, 0 worksMaterials ScienceDentistry: 1.55× its world share, 0 worksDentistryHealth Professions: 0.84× its world share, 1 worksHealth ProfessionsMedicine: 3.75× its world share, 21 worksMedicineNursing: 1.92× its world share, 0 worksNursingVeterinary: 0.83× its world share, 0 worksVeterinaryPsychology: 1.11× its world share, 1 worksPsychology1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 9.7×. Every wedge is a field page.

All 14 fields, with their numbers
  1. Immunology and Microbiology9.70×3 works
  2. Pharmacology, Toxicology and Pharmaceutics4.16×0 works
  3. Medicine3.75×21 works
  4. Nursing1.92×0 works
  5. Dentistry1.55×0 works
  6. Psychology1.11×1 works
  7. Biochemistry, Genetics and Molecular Biology1.03×2 works
  8. Health Professions0.84×1 works
  9. Neuroscience0.83×0 works
  10. Veterinary0.83×0 works
  11. Chemistry0.48×0 works
  12. Agricultural and Biological Sciences0.20×0 works
  13. Engineering0.04×0 works
  14. Materials Science0.03×0 works

Who are the top researchers at Galderma (Switzerland)?

Ranked on the quality score, Valérie Julia, Rajeev Chavda and Christophe Piketty lead among researchers whose main affiliation is Galderma (Switzerland).

  1. 1 Valérie Julia Switzerland · #453,695 worldwide 3.2k citations · 69 works
  2. 2 Rajeev Chavda Switzerland · #498,462 worldwide 1.7k citations · 90 works
  3. 3 Christophe Piketty Switzerland · #500,197 worldwide 5.9k citations · 173 works
  4. 4 Prasad Chaskar Switzerland · #976,175 worldwide 1k citations · 21 works
  5. 5 Jayendra Kumar Krishnaswamy Switzerland · #1,037,209 worldwide 1.3k citations · 30 works
  6. 6 Liliana Ulianov Switzerland · #1,820,963 worldwide 318 citations · 28 works
  7. 7 Sylvie Gabriel Switzerland · #1,967,157 worldwide 2.3k citations · 141 works
  8. 8 Rajesh Rout Switzerland · #2,458,238 worldwide 133 citations · 14 works
  9. 9 Jorge Puelles Switzerland · #2,741,603 worldwide 628 citations · 48 works
  10. 10 Nadège Lachmann Switzerland · #3,924,859 worldwide 474 citations · 39 works
All ranked researchers at Galderma (Switzerland)

What are the most cited papers from Galderma (Switzerland)?

The most cited paper from Galderma (Switzerland) is "Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis" (Sonja Ständer, Gil Yosipovitch, Franz Josef Legat et al., 2020), with 281 citations. Next come "Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus" (275) and "Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis" (189).

Most cited papers
#PaperReleasedCitations
1 Trial of Nemolizumab in Moderate-to-Severe Prurigo Nodularis Sonja Ständer, Gil Yosipovitch, Franz Josef Legat et al. · New England Journal of Medicine Open access 19 Feb 2020 281
2 Phase 2B randomized study of nemolizumab in adults with moderate-to-severe atopic dermatitis and severe pruritus Jonathan I. Silverberg, Andreas Pinter, Grażyna Pulka et al. · Journal of Allergy and Clinical Immunology Open access 23 Aug 2019 275
3 Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis Shawn G. Kwatra et al. · New England Journal of Medicine Open access 25 Oct 2023 189
4 Single-cell analysis of human skin identifies CD14+ type 3 dendritic cells co-producing IL1B and IL23A in psoriasis Satoshi Nakamizo et al. · The Journal of Experimental Medicine Open access 16 Jun 2021 172
5 Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials Jonathan I. Silverberg et al. · The Lancet 24 Jul 2024 156
All 60 most cited papers, with filters and sorting

Which keywords describe research at Galderma (Switzerland)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Epidemiology, Filaggrin, Skin Microbiome, Quality of Life, Treatment, Diagnosis, Regulatory T Cells and Immune System.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Epidemiology8▲ 6.6×14 topics
  2. Filaggrin6▲ 438×1 topic
  3. Skin Microbiome6▲ 438×1 topic
  4. Quality of Life4▲ 9.2×9 topics
  5. Treatment4▲ 9.7×5 topics
  6. Diagnosis3▲ 12×5 topics
  7. Inflammation3▲ 4.2×8 topics
  8. Regulatory T Cells3▲ 76×2 topics
  9. IL-172▲ 227×1 topic
  10. Immune System2▲ 35×2 topics
  11. TH17 Cells2▲ 227×1 topic
  12. Management2▲ 9.1×4 topics
  13. Autoantibodies2▲ 29×3 topics
  14. Autoimmune2▲ 148×2 topics
  15. Asthma2▲ 64×2 topics
  16. Chronic Spontaneous Urticaria2▲ 256×1 topic
  17. Urticaria2▲ 256×1 topic
  18. Photodynamic Therapy2▲ 22×3 topics
  19. Inflammatory Disease1▲ 96×1 topic
  20. Prurigo Pigmentosa1▲ 460×1 topic
  21. Acne Vulgaris1▲ 225×1 topic
  22. Allergen-specific Immunotherapy1▲ 138×1 topic
  23. Antifungal Therapy1▲ 50×3 topics
  24. Climate Change1▲ 1.64×2 topics
  25. Pollen Allergy1▲ 138×1 topic
  26. Rosacea1▲ 225×1 topic

Which research topics does Galderma (Switzerland) publish most on?

By volume in 2022-now: Dermatology and Skin Diseases, Psoriasis: Treatment and Pathogenesis, Urticaria and Related Conditions and Medicine and Dermatology Studies History.

Dermatology and Skin Dis…6Dermatology and Skin Diseases: 6 fractional worksPsoriasis: Treatment and…2Psoriasis: Treatment and Pathogenesis: 2 fractional worksUrticaria and Related Co…2Urticaria and Related Conditions: 2 fractional worksMedicine and Dermatology Studies History: 1 fractional worksAllergic Rhinitis and Sensitization: 1 fractional worksAcne and Rosacea Treatme…1Acne and Rosacea Treatments and Effects: 1 fractional worksNail Diseases and Treatments: 1 fractional worksSkin Protection and Aging: 1 fractional worksFacial Rejuvenation and Surgery Techniques: 1 fractional worksDermatologic Treatments and Research: 1 fractional works
DermatologyImmunologyRheumatologyImmunology and Allergy1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Dermatology and Skin Diseases Dermatology 6 works
  2. 2 Psoriasis: Treatment and Pathogenesis Immunology 2 works
  3. 3 Urticaria and Related Conditions Rheumatology 2 works
  4. 4 Medicine and Dermatology Studies History Dermatology 1 works
  5. 5 Allergic Rhinitis and Sensitization Immunology and Allergy 1 works
  6. 6 Acne and Rosacea Treatments and Effects Dermatology 1 works
  7. 7 Nail Diseases and Treatments Epidemiology 1 works
  8. 8 Skin Protection and Aging Dermatology 1 works
  9. 9 Facial Rejuvenation and Surgery Techniques Dermatology 1 works
  10. 10 Dermatologic Treatments and Research Dermatology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available61.0%not open39.0%

World: 40% of research is openly available.

with international co-authors81.7%domestic only18.3%

World: 18% is written across borders.

How has Galderma (Switzerland)'s research output changed?

Output in 2022-2025 was 46% higher than in 2018-2021.

still counting201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Galderma (Switzerland) as a percentage of every work published that year, 0.00016% in 2024.

still counting0.00010%0.00020%Galderma (Switzerland)0.00014% in 20252020

Fractional works of Galderma (Switzerland) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Lausanne

All research institutions in Lausanne

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Galderma (Switzerland). Posts are plain text and can be reported.